UniPert-G2CP bridges genetic and chemical screens from molecular representation to phenotype modeling.

July 24, 2026| Source: Cell

Systematically simulating and predicting phenotypic effects of diverse interventions across heterogeneous cellular environments is central to the vision of artificial intelligence virtual cell (AIVC). However, disparities in perturbagen modalities, assay formats, and data production efficiency hinder unified modeling and analysis of genetic and chemical screens. This study presents UniPert-G2CP, a two-stage deep learning framework that bridges genetic and chemical screens by unifying multimodal molecular perturbagen (cause) representations and enabling genetic-to-chemical perturbation phenotype (effect) transfer learning. Validated on large-scale genetic and chemical screening datasets, UniPert-G2CP enables more efficient, accurate, robust, interpretable, and generalizable simulation of multicellular and multidomain perturbation cause-effect spaces. Further joint analysis of these spaces reveals cellular heterogeneity underlying drug responses, providing mechanistic insights into drug action and resistance. Collectively, UniPert-G2CP advances universal biological causal modeling, accelerates AIVC realization, and expands the potential of AI-powered precision medicine.

Read the original source →

PLK1-mediated phosphorylation of PHGDH reprograms serine metabolism in advanced prostate cancer.

Metabolic reprogramming is a hallmark of cancer, enabling tumor cells to meet their increased biosynthetic and energetic demands. Although cells possess the capacity for de novo serine biosynthesis, most transformed cancer cells preferentially rely on exogenous serine uptake to sustain their growth, yet the regulatory mechanisms driving this metabolic dependency remain poorly understood. Here, we uncover a mechanism by which Polo-like kinase 1 (PLK1), frequently overexpressed in prostate cancer,

Artificial IntelligenceAugust 4, 2026

When coordination is avoidable: A monotonicity analysis of organizational tasks.

Organizations devote substantial resources to coordination, yet which tasks actually require it for correctness remains unclear. The problem is acute in multiagent AI systems, where coordination cost is directly measurable and can exceed the cost of the work itself. Distributed systems theory provides a precise criterion: Coordination is required when a task specification is nonmonotonic, meaning that as histories grow, new information can invalidate prior conclusions. Here we show that Thompson

Artificial IntelligenceJuly 30, 2026

Dapagliflozin and Acute Kidney Injury Following Cardiac Surgery: A Randomized Clinical Trial.

Two percent to 50% of patients undergoing elective cardiac surgery experience acute kidney injury (AKI) postoperatively. Medications to prevent AKI after elective cardiac surgery have not been identified. In patients undergoing elective cardiac surgery, to evaluate whether initiating dapagliflozin 1 day prior to surgery reduces the incidence of AKI at 7 days after cardiac surgery, compared with placebo. Multicenter, double-blind, placebo-controlled randomized clinical trial conducted at 2 academ

Artificial IntelligenceJuly 28, 2026

Context-aware multimodal AI navigates hidden pathways in five centuries of art evolution.

The rise of multimodal generative AI transforms the intersection of technology and art, offering richer insights into large-scale artworks. While significant research has focused on their creative potential, their ability to represent artworks in latent spaces remains underexamined. We use generative AI, specifically Stable Diffusion, to analyze 500 y of Western paintings by extracting two types of latent information with the model: formal aspects (e.g., colors) and contextual aspects (e.g., sub

Artificial IntelligenceJuly 27, 2026

Advancing cancer detection and treatment using longitudinal routine clinical data.

Cancer management remains fragmented across its continuum, from late-stage diagnosis and salvage therapies to non-personalized surveillance. Here, we present Oncoformer, a unified multimodal transformer model trained on the China Oncology Multimodal Prediction and Surveillance Study (COMPASS) cohort (3.67 million individuals, 17.7 million clinical visits) and validated on independent external cohorts, including the UK Biobank. Oncoformer integrates longitudinal electronic health records with che